BioForce Nanosciences

(OTC) BFNH

Current Price$1.79

Market Cap$60.05M

Since IPO (2006)+258%

5 Year-1%

1 Year+239%

1 Month+225%

BioForce Nanosciences Financials at a Glance

Market Cap

$60.05M

Revenue (TTM)

$0.00

Net Income (TTM)

-$458.91K

EPS (TTM)

-$0.01

P/E Ratio

-130.66

Dividend

$0.00

Beta (Volatility)

-0.36 (Low)

Dividend

$0.00

Beta (Volatility)

-0.36 (Low)

Price

$1.79

Volume

7,070

Open

$1.73

Price

$1.79

Volume

7,070

Open

$1.73

Previous Close

$1.79

Daily Range

$1.28 - $1.80

52-Week Range

$0.18 - $1.88

Estimated Earnings Date

May 19, 2026

Dividend

$0.00

Beta (Volatility)

-0.36 (Low)

Price

$1.79

Volume

7,070

Open

$1.73

Previous Close

$1.79

Daily Range

$1.28 - $1.80

52-Week Range

$0.18 - $1.88

Estimated Earnings Date

May 19, 2026

BFNH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioForce Nanosciences

Industry

Personal Products

Sector

Consumer Staples

Employees

CEO

Steven F. Gagnon; John S. LaViolette

Website

bioforceeclipse.com

Headquarters

Virginia Beach, VA 23454, US

BFNH Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

66%

Return on Assets

-72%

Earnings Yield

-0.77%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$60.05M

Shares Outstanding

33.55M

Volume

7.07K

Avg. Volume

2.54K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$489.95K

EBITDA

-$489.95K

Operating Cash Flow

-$65.15K

Capital Expenditure

$0.00

Free Cash Flow

-$65.15K

Cash & ST Invst.

$786.00

Total Debt

$0.00

BioForce Nanosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$60.05M

N/A

Market Cap/Employee

$20.02M

N/A

Employees

N/A

Net Income

-$102.41K

+89.0%

EBITDA

-$117.73K

+11.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$6.35K

-54.0%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-72.30%

N/A

Return on Invested Capital

65.78%

N/A

Free Cash Flow

$7.09K

+146.6%

Operating Cash Flow

$7.09K

+146.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ELAMFElamex S.A. de CV

ELAMFElamex S.A. de CV$2.80+0.00%

DTEAFDAVIDsTEA Inc.

DTEAFDAVIDsTEA Inc.$0.71+0.00%

NPRFFNepra Foods Inc.

NPRFFNepra Foods Inc.$0.16-6.98%

IRCKFInter-Rock Minerals Inc.

IRCKFInter-Rock Minerals Inc.$0.74+0.00%

HNFSAHanover Foods Corporation

HNFSAHanover Foods Corporation$50.00+0.00%

CFOOChina Foods Holdings Ltd.

CFOOChina Foods Holdings Ltd.$0.66+0.00%

INBPIntegrated BioPharma, Inc.

INBPIntegrated BioPharma, Inc.$0.18+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ASTSAST SpaceMobile

ASTSAST SpaceMobile$82.41-0.16%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.59+0.01%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$721.34+0.01%

Questions About BFNH

What is the current price of BioForce Nanosciences?

BioForce Nanosciences is trading at $1.79 per share.

What is the 52-week range for BioForce Nanosciences?

Over the past 52 weeks, BioForce Nanosciences has traded between $0.18 and $1.88.

How much debt does BioForce Nanosciences have?

As of the most recent reporting period, BioForce Nanosciences reported total debt of $0.00.

How much cash does BioForce Nanosciences have on hand?

BioForce Nanosciences reported $6.35K in cash and cash equivalents in its most recent financial results.

What is BioForce Nanosciences’s dividend yield?

BioForce Nanosciences does not currently have a dividend yield.

BioForce Nanosciences

BioForce Nanosciences Financials at a Glance

BFNH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioForce Nanosciences

BFNH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioForce Nanosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BFNH

What is the current price of BioForce Nanosciences?

What is the 52-week range for BioForce Nanosciences?

How much debt does BioForce Nanosciences have?

How much cash does BioForce Nanosciences have on hand?

What is BioForce Nanosciences’s dividend yield?

Premium Investing Services